Atria Investments’s F/m Emerald Life Sciences Innovation ETF LFSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.11M Buy
24,506
+2,161
+10% +$83.6K 0.01% 1055
2026
Q1
$782K Buy
+22,345
New +$793K 0.01% 1200

Other funds holding LFSC

Atria Investments's LFSC Position: Q2 2026 in Review

Atria Investments increased its F/m Emerald Life Sciences Innovation ETF (LFSC) stake by 9.7% in Q2 2026, buying an estimated $83.6K and bringing the position to 24,506 shares worth $1.11M. The position accounts for 0.01% of the portfolio, ranked #1055.

Atria Investments first reported a position in LFSC in Q1 2026 and has held it in 2 quarters since. 8 funds tracked by Wall St. Rank hold LFSC as of Q2 2026.

  • Atria Investments held 24,506 shares of F/m Emerald Life Sciences Innovation ETF worth $1.11M as of Q2 2026.
  • Atria Investments bought 2,161 F/m Emerald Life Sciences Innovation ETF shares in Q2 2026, an estimated $83.6K.
  • F/m Emerald Life Sciences Innovation ETF made up 0.01% of Atria Investments's portfolio in Q2 2026, its #1055 holding.
  • Atria Investments first reported a position in F/m Emerald Life Sciences Innovation ETF in Q1 2026 and has held it in 2 quarters since.
  • 8 funds tracked by Wall St. Rank held F/m Emerald Life Sciences Innovation ETF as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.